Inve India ▾

Balaji Amines share price & results

Balaji Amines Limited· Chemicals· Commodities

Results to
Jun 2026
Latest analysed call
Q4 FY26
Ownership as of
Sept 2026

India's largest manufacturer of aliphatic amines and methylamines, serving pharma, agro and EV battery makers.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue456 ₹ crore+27.4% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin25.0 %+10.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit78.0 ₹ crore+110.8% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity10.68 %−0.1 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-13.11 %−18.0 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)11.09 %+17.0 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

1 of 5 judged targets kept · 11 open · verdicts reflect calls analysed to Q4 FY26.

Balaji Amines Limited management guidance track record on Inve: 16 targets tracked across analysed earnings calls (1 achieved, 4 missed, 11 open).

TargetOriginal wordingSaidLatest callVerdict
Methylamine CommissioningQ2 FY25Q2 FY24Q4 FY26:Promise remains achieved.
Call transcript, Q4 FY26 · 18 May 2026		Achieved
FY25 EBITDA Margin21% to 24% for FY25Q4 FY24Q4 FY26:Promise period has passed. The final outcome remains 'missed'.
Call transcript, Q4 FY26 · 18 May 2026		Missed
Dimethyl Ether CommissioningH1 FY25Q2 FY24Q4 FY26:Commissioning is now expected during Q1 FY27. Plant is constructed but transportation approvals are still pending.
Call transcript, Q4 FY26 · 18 May 2026		Delayed

Source: Inve Guidance Tracker for Balaji Amines Limited · to Q4 FY26

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

4 of Balaji Amines Limited's 16 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 13 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹1,861.3 +2.53% · +₹45.9

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance +33.5% 1Y

₹1.0k₹1.5k₹2.0k₹2.5kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 12 Nov 2025Q4 FY26 — 18 May 2026

1Y: ₹1,394 on 24 Oct 2025 → ₹1,861.3. High ₹2,566.8 (7 Sept 2026), low ₹977.2 (30 Mar 2026).

Previous close
₹1,815.4
Market cap
₹5.9k Cr
52-week range
₹977.2 – ₹2,566.8
One year
+32.65%
Price to earnings (TTM to Jun 2026)
28.83×
Return on equity (TTM to Jun 2026)
10.68%

Overview

Symbol
NSE:BALAMINES
Sector
Chemicals
Industry
Commodities
Exchange
NSE
Currency
INR

What Balaji Amines Limited does

Based on the company's own presentations, annual report and earnings calls.

Balaji Amines Limited manufactures aliphatic amines, amine derivatives and specialty chemicals used across pharmaceuticals, agrochemicals, dyes, rubber, animal feed, water treatment and electric-vehicle battery applications. It is India's largest manufacturer of aliphatic amines and the country's largest producer of methylamines, built on indigenously developed process technology, with roughly 80% of its methylamine output captively consumed to make higher-value derivatives and specialty chemicals. The company exports to over 50 countries including Europe, the USA and Japan, and is expanding downstream through its subsidiary Balaji Speciality Chemicals Limited into ethylenediamine-based products, hydrogen cyanide, sodium cyanide and EDTA derivatives.

Segments

  • Amines
  • Amine Derivatives
  • Specialty & Other Chemicals
Installed manufacturing capacity
2,93,600 TPA
Manufacturing facilities
4 plants (Units I, III & IV in Solapur, Maharashtra, plus one facility near Hyderabad)
Market position
Largest manufacturer of aliphatic amines in India; largest producer of methylamines in India
Product portfolio
40+ products across amines, amine derivatives and specialty chemicals
Countries served (exports)
50+ countries, including Europe, the USA and Japan
International clients
65+ international clients
Founded 1988Headquarters Solapur, Maharashtra, India Company website

How the price took the results

close before → close after

Q4 FY26
+3.3%
18 May
Q2 FY26
−1.7%
12 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Balaji Amines Limited

Free account: one company. Everything above stays public.

Write why you follow Balaji Amines Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Chemicals companies

All Chemicals companies → · Chemicals earnings growth →

Learn to analyse Balaji Amines Limited

Guides on how to read this kind of business and the numbers that matter.